GlassScriptPhysician profile
Dawn M Mormak
NPI 1689963696
$2,873.77
in general payments reported to CMS, 2019-2025
29 companies · $470 in 2025
The $470 reported for 2025 was more than what 79% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $224 · 2021: $278 · 2022: $658 · 2023: $668 · 2024: $576 · 2025: $470.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,615 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,615.19 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $428.64 | 2023-2025 | Veozah, Myrbetriq |
| Mayne Pharma Commercial LLC | $309.90 | 2022-2025 | |
| Shield Therapeutics INC | $207.52 | 2023-2024 | Accrufer |
| Therapeuticsmd, INC. | $167.19 | 2019-2022 | |
| Hologic Sales and Service, LLC | $165.51 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $153.46 | 2019-2023 | |
| Sage Therapeutics, LLC | $143.86 | 2025 | Zurzuvae |
| Sumitomo Pharma America, INC. | $140.57 | 2023-2025 | Myfembree, Gemtesa |
| Agile Therapeutics, INC. | $135.19 | 2021-2024 | Twirla |
| Abbvie INC. | $131.89 | 2021-2023 | Liletta |
| Exeltis, USA INC. | $124.65 | 2023-2025 | Slynd |
| Pfizer INC. | $108.34 | 2023-2025 | |
| Organon LLC | $90.72 | 2022-2024 | Nexplanon |
| Myovant Sciences INC. | $76.06 | 2021-2022 | |
| Scynexis, INC. | $73.51 | 2022 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Evofem Biosciences, INC. | $44.36 | 2022-2023 | Phexxi |
| Avion Pharmaceuticals | $44.16 | 2022 | |
| Baxter Healthcare | $42.68 | 2022 | |
| Exact Sciences Corporation | $41.09 | 2023 | Cologuard Collection Kit |
| Millicent US INC | $39.40 | 2025 | Intrarosa, Femring |
| Coopersurgical, INC. | $38.72 | 2022-2025 | Paragard T 380a |
| Lupin INC. | $34.87 | 2019 | |
| Merck Sharp & Dohme LLC | $33.04 | 2019-2023 | Gardasil 9 |
| Supernus Pharmaceuticals, INC. | $19.91 | 2025 | Qelbree |
| Allergan, INC. | $19.30 | 2019 | |
| Davol INC. | $18.08 | 2023 | Arista Ah Flexitip |
| Mimedx Group, INC. | $15.39 | 2025 | |
| Vertical Pharmaceuticals, LLC | $14.00 | 2019 | |
| Minerva Surgical, INC | $11.76 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dawn Mormak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.